CCL22 and Alzheimer disease: Our study also demonstrated that TLR2 activation promoted PBMCs from AD patients expressed higher chemokines CCL5, CCL8, CCL13, CCL18, and CCL22, which mainly recruited eosinophils and Th2 cells.